Diabetes Medication Article

Types of Insulin Delivery Devices

All insulin delivery devices inject insulin through the skin and into the fatty tissue below.
Most people inject the insulin with a syringe that delivers insulin just under the skin. Others use insulin pens, jet injectors, or insulin pumps. Several new approaches for taking insulin are under development.

Jet Injectors
Insulin jet injectors may be an option for people who do not want to use needles. These devices use high pressure air to send a find spray of insulin through the skin. Jet injectors have no needles.

Diabetes Testing Center
Heart News Center
Hot Home Gym Reviews
The Secret Wisdom You Have Inside
Get Rid of Your Belly fat

Byetta Medication News


Byetta Medication

Go to the new RSS page and renew your subscription.]]>

Read more



IMPORTANT: Bing News RSS feed has moved!

Bydureon uses technology developed by Alkermes to slowly release exenatide into the bloodstream with one dose a week. The drug won European Commission approval in June. “Bydureon’s approval in the U.S. will not solve Amylin’s current ...

Read more



Amylin, Alkermes Long-Acting Diabetes Drug Wins FDA Approval on Third Try

The Food and Drug Administration approved the drug for adults with Type 2 diabetes, the agency said today in a letter posted on their website. Bydureon is a long-acting form of Byetta, a twice-daily injection that San Diego-based Amylin ...

Read more



Amylin, Alkermes Diabetes Drug Wins Approval on Third Try

Therefore, you only have to give it once a week. Bydureon is "once-a-week Byetta." Many things about this drug are very similar to Byetta. Byetta is a GLP-1 agonist. These drugs work like GLP-1 in the body: They improve insulin secretion ...

Read more



Bydureon: An Easy, Effective New Treatment for Type 2 Diabetes

January 27, 2012 — The US Food and Drug Administration (FDA) today approved a once-weekly extended-release formulation of exenatide injection (Bydureon, Amylin Pharmaceuticals) as an adjunct to diet and exercise to improve glycemic control in ...

Read more



Once-Weekly Exenatide Okayed by FDA for T2DM After Long Look

... lawyers at The Eichholz Law Firm are seeking diabetes patients who were prescribed Byetta and later suffered from kidney failure or pancreatitis. The dangerous drug attorneys are offering free and confidential case evaluations for all those that ...

Read more



Savannah Byetta Lawyers Seeking Individuals with Pancreatitis and Kidney Failure

Bydureon is an injectable, extended-release version of Amylin's older diabetes drug, Byetta, which is injected twice daily. Byetta and Bydureon share an active ingredient, exenatide. Bydureon was approved for sale by European regulators in June.

Read more



FDA Approves Amylin's Bydureon Diabetes Drug

the new drug from Amylin and Alkermes is the first treatment that can be injected as little as once a week. Amylin has been marketing the original form of exenatide (Byetta) as a twice-daily injectable since 2005. About 25 million people in ...

Read more



Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug

The Food and Drug Administration approved the drug for adults with Type 2 diabetes, the agency said Friday in a letter posted on their website. Bydureon is a long-acting form of Byetta, a twice-daily injection that San Diego-based Amylin developed with Eli ...

Read more



Lilly's ex-partner wins FDA approval for diabetes drug

The approval follows two earlier rejections in 2010, when the FDA asked the company to go back and carry out a new trial of the drug's effect on heart rhythm. The company describes Bydureon (exenatide extended-release for injectable suspension ...

Read more


Byetta Medication Links